SEQIRUS VACCINES LIMITED – MIA 18532
| Authorisation Number | UK MIA 18532 |
| Category | MIA |
| Holder | SEQIRUS VACCINES LIMITED |
| Registered Address | SEQIRUS VACCINES LIMITED, GASKILL ROAD, SPEKE, LIVERPOOL, L24 9GR, UNITED KINGDOM |
| Authorisation Date | Jun 29, 2026 |
| Legal Basis | HumanRegulation 17 of The Human Medicines Regulations 2012 (SI 2012/1916) |
| Sites | 1 |
| Manufacturing Operations | 1.1 1.1.1 1.1.1.6 1.3 1.3.1 1.3.1.2 1.3.1.8 1.3.2 1.3.2.2 1.3.2.8 1.4 1.4.2 1.4.2.1 1.5 1.5.1 1.5.1.17 1.5.2 1.6 1.6.1 1.6.2 1.6.3 1.6.4 |
| Importation Operations | 2.1 2.1.1 2.1.2 2.1.3 2.1.4 2.2 2.2.1 2.2.1.1 2.2.1.2 2.2.3 2.2.3.2 2.2.3.8 2.3 2.3.1 2.3.2 2.3.3 2.3.4 |
| MHRA Link | View on MHRA Website |
Sites (1)
SEQIRUS VACCINES LIMITED
BOTH
Country: UNITED KINGDOMProduct Class: Human Medicinal Products
Manufacturing
1.1 — Sterile Products
1.1.1 — Aseptically prepared (processing operations for the following dosage forms)
1.1.1.6 — Other aseptically prepared products
1.3 — Biological medicinal products
1.3.1 — Biological medicinal products
1.3.1.2 — Immunological products
1.3.1.8 — Other biological medicinal products
1.3.2 — Batch certification
1.3.2.2 — Immunological products
1.3.2.8 — Other biological medicinal products
1.4 — Other products or manufacturing activity
1.4.2 — Sterilisation of active substances/excipients/finished products:
1.4.2.1 — Filtration
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.17 — Other non-sterile medicinal products
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.1 — Microbiological: sterility
1.6.2 — Microbiological: non-sterility
1.6.3 — Chemical/Physical
1.6.4 — Biological
Importation
2.1 — Quality control testing of imported medicinal products
2.1.1 — Microbiological: sterility
2.1.2 — Microbiological: non-sterility
2.1.3 — Chemical/Physical
2.1.4 — Biological
2.2 — Batch certification of imported medicinal products
2.2.1 — Sterile Products
2.2.1.1 — Aseptically prepared
2.2.1.2 — Terminally sterilised
2.2.3 — Biological medicinal products
2.2.3.2 — Immunological products
2.2.3.8 — Other biological medicinal products
2.3 — Other Importation Activities
2.3.1 — Site of Physical Importation
2.3.2 — Importation of Intermediate which undergoes further processing
2.3.3 — Biological Active Substance
2.3.4 — Products authorised under regulation 174 (supply in response to spread of pathogenic agents etc)
Content Preview
The source document is available on KeyPedia. Sign in to view.